Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016;9:45–53. https://doi.org/10.2147/JAA.S86251.

Article  PubMed  PubMed Central  Google Scholar 

Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25(4):205–8. https://doi.org/10.2500/ajra.2011.25.3613.

Article  PubMed  Google Scholar 

Philpott CM, Erskine S, Hopkins C, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study. Respir Res. 2018;19(1):129. https://doi.org/10.1186/s12931-018-0823-y.

Article  PubMed  PubMed Central  Google Scholar 

Wu D, Bleier BS, Li L, et al. Clinical phenotypes of nasal polyps and comorbid asthma based on cluster analysis of disease history. J Allergy Clin Immunol Pract. 2018;6(4):1297-305.e1. https://doi.org/10.1016/j.jaip.2017.09.020.

Article  PubMed  Google Scholar 

•• Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58:1–464. https://doi.org/10.4193/Rhin20.600. First international guideline which emphasizes the role of the endotype as an essential prerequisite for precision medicine, providing the essential foundation for the start of the use of biologics in normal clinical practice.

Article  PubMed  Google Scholar 

Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6(1):86. https://doi.org/10.1038/s41572-020-00218-1.

Article  PubMed  Google Scholar 

Wallace DV. Treatment options for chronic rhinosinusitis with nasal polyps. Allergy Asthma Proc. 2021;42(6):450–60. https://doi.org/10.2500/aap.2021.42.210080.

Article  CAS  PubMed  Google Scholar 

• De Corso E, Bellocchi G, De Benedetto M, Lombardo N, Macchi A, Malvezzi L, et al. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital. 2022;42(1):1–16. https://doi.org/10.14639/0392-100X-N1614. First Italian position paper published after the approval of biologics in Italy in which the value of multidisciplinarity is greatly stressed.

De Corso E, Pipolo C, Cantone E, Ottaviano G, Gallo S, Canevari FRM, et al. Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs. J Pers Med. 2022;12(6):897. https://doi.org/10.3390/jpm12060897.

Article  PubMed  PubMed Central  Google Scholar 

Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36.

Article  CAS  PubMed  Google Scholar 

• De Corso E, Ottaviano G, Pipolo C, Cantone E, Mattavelli D, Alicandri-Ciufelli M, et al. Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice. J Pers Med. 2023;13(11):1531. https://doi.org/10.3390/jpm13111531. Italian survey from which the need for a clinical definition of disease control in clinical practice and for specific tools to measure it clearly emerges.

Article  PubMed  PubMed Central  Google Scholar 

Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449-56.e4. https://doi.org/10.1016/j.jaci.2015.12.1324.

Article  CAS  PubMed  Google Scholar 

Bachert C, Zhang N, Hellings PW, Bousquet J. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018;141(5):1543–51. https://doi.org/10.1016/j.jaci.2018.03.004.

Article  PubMed  Google Scholar 

De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22. https://doi.org/10.1186/s13601-017-0157-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638–50. https://doi.org/10.1016/S0140-6736(19)31881-1.

Article  CAS  PubMed  Google Scholar 

van der Lans RJL, Fokkens WJ, Adriaensen GFJPM, Hoven DR, Drubbel JJ, Reitsma S. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy 2022;77:670–4. https://doi.org/10.1111/all.15134.

Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605. https://doi.org/10.1016/j.jaci.2020.05.032.

Article  CAS  PubMed  Google Scholar 

Gevaert P, Saenz R, Corren J, Han JK, Mullol J, Lee SE, et al. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol. 2022;149(3):957-65.e3. https://doi.org/10.1016/j.jaci.2021.07.045.

Article  CAS  PubMed  Google Scholar 

Desrosiers M, Diamant Z, Castelnuovo P, Hellings PW, Han JK, Peters AT, et al. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up. Int Forum Allergy Rhinol. 2023;14(1):18–31. https://doi.org/10.1002/alr.23219.

Article  PubMed  Google Scholar 

Hopkins C, Han JK, Lund VJ, Bachert C, Fokkens WJ, Diamant Z, et al. Evaluating treatment response to mepolizumab in patients with severe CRSwNP. Rhinology. 2023;61(2):108–17. https://doi.org/10.4193/Rhin22.200.

Article  CAS  PubMed  Google Scholar 

• De Corso E, Pipolo C, Cantone E, Ottaviano G, Gallo S, Trimarchi M, et al. Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics. Acta Otorhinolaryngol Ital. 2023;43(5):324–40. https://doi.org/10.14639/0392-100X-N2422 . Italian position paper which highlights through a survey the needs that emerge from the daily use of biologics in normal clinical practice.

•• Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74:2312–9. https://doi.org/10.1111/all.13875. First paper in which the criteria for the indication of CRSwNPs to biological drugs are defined.

Article  PubMed  Google Scholar 

De Corso E, Bilò MB, Matucci A, Seccia V, Braido F, Gelardi M, et al. Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. J Pers Med. 2022;12(5):846. https://doi.org/10.3390/jpm12050846.

Article  PubMed  PubMed Central  Google Scholar 

Lombardi C, Asero R, Bagnasco D, Blasi F, Bonini M, Bussi M, et al. ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments. World Allergy Organ J. 2021;14: 100592. https://doi.org/10.1016/j.waojou.2021.100592.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hopkins C, McKenzie JL, Anari S, Carrie S, Ramakrishnan Y, Kara N, et al. British Rhinological Society consensus guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol. 2021;46:1037–43. https://doi.org/10.1111/coa.13779.

Article  PubMed  Google Scholar 

•• Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, et al. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024 Jan 13. https://doi.org/10.4193/Rhin23.415. Epub ahead of print. PMID: 38217529. Expert opinion including new definitions such as Control of disease and Remission.

Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2021;50:15. https://doi.org/10.1186/s40463-021-00493-2.

Article  Google Scholar 

Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, et al. American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. J Clin Oncol. 2012;30(25):3136–40. https://doi.org/10.1200/JCO.2012.42.0489.

Article  PubMed  Google Scholar 

Humphrey-Murto S, Varpio L, Wood TJ, Gonsalves C, Ufholz LA, Mascioli K, et al. The Use of the Delphi and Other Consensus Group Methods in Medical Education Research: A Review. Acad Med. 2017;92(10):1491–8. https://doi.org/10.1097/ACM.0000000000001812.

Article  PubMed  Google Scholar 

•• Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61(3):194–202. https://doi.org/10.4193/Rhin22.489. Important update on indications for biologics and evaluation of success.

Article  CAS  PubMed  Google Scholar 

Khoury P, Akuthota P, Kwon N, Steinfeld J, Roufosse F. HES and EGPA: Two Sides of the Same Coin. Mayo Clin Proc. 2023;98(7):1054–70. https://doi.org/10.1016/j.mayocp.2023.02.013.

Article  CAS  PubMed  Google Scholar 

Cantone E, De Corso E, Ricciardiello F, Di Nola C, Grimaldi G, Allocca V, et al. Olfaction recovery following dupilumab is independent of nasal polyp reduction in CRSwNP. J Pers Med. 2022;12:1215. https://doi.org/10.2174/1570159X20666220420113513.

Article  PubMed  PubMed Central  Google Scholar 

Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, et al. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. Int Arch Allergy Immunol. 2022;183(3):279–88. https://doi.org/10.1159/000519228.

Article  CAS  PubMed  Google Scholar 

Shen Y, Ke X, Hong S, Yang Y. Adverse events for biologics in patients with CRSwNP: A meta-analysis. Clin Transl Allergy. 2022;12(6): e12169. https://doi.org/10.1002/clt2.12169.

Article  PubMed  PubMed Central  Google Scholar 

Reitsma S, Adriaensen G, Cornet ME, van Haastert RM, Raftopulos MH, Fokkens WJ. The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgery. Rhinology. 2020;58(6):538–43. https://doi.org/10.4193/Rhin20.165.

Article  CAS  PubMed  Google Scholar 

Loftus CA, Soler ZM, Desiato VM, Koochakzadeh S, Yoo F, Storck KA, et al. Factors impacting revision surgery in patients with chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2020;10(3):289–302. https://doi.org/10.1002/alr.22505.